Stock TLIS TALIS BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:30:00 02/05/2024 BST 		5-day change 1st Jan Change
9.1 USD +1.17% Intraday chart for Talis Biomedical Corporation +1.11% +22.15%
04-02 North American Morning Briefing : Stocks Seen -2- DJ
03-28 Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The Company is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud database, which work together and are designed to provide central laboratory levels of accuracy and be operated by an untrained user. It is also focused on developing Talis One assay kits for respiratory infections, and infections related to women's health and sexually transmitted infections (STIs). It is also developing influenza A and influenza B tests to be included as part of a respiratory panel with its COVID-19 assay (Respiratory Panel), as well as exploring adding a respiratory syncytial virus (RSV) test.

Number of employees: 99

Sales per Business

USD in Million2022Weight2023Weight Delta
Grant
80.7 %
1 24.1 % 2 80.7 % +48.45%
Antigen Tests Products
19.3 %
4 75.9 % 0 19.3 % -88.72%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
5 100.0 % 2 100.0 % -55.65%

Managers

Managers TitleAgeSince
Robert Kelley CEO
 Chief Executive Officer 52 31/08/20
Rebecca Markovich DFI
 Director of Finance/CFO 51 31/12/21
Kim Popovits BRD
 Director/Board Member 65 30/07/20
Emily Faucette IRC
 Investor Relations Contact - 31/12/20
Gillian Green
- -
Matthew Pepe HRO
 Human Resources Officer - 30/04/21
Jill Green LAW
 General Counsel - 31/12/19

Members of the board

Members of the board TitleAgeSince
Matthew Posard BRD
 Director/Board Member 56 29/02/16
Randal Scott BRD
 Director/Board Member 66 31/12/13
Kim Popovits BRD
 Director/Board Member 65 30/07/20
Robert Kelley CEO
 Chief Executive Officer 52 31/08/20
Heiner Dreismann BRD
 Director/Board Member 69 18/05/23
Rustem Ismagilov FOU
 Founder 50 25/06/13
Raymond Cheong BRD
 Director/Board Member 42 31/05/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,821,986 1,670,630 ( 91.69 %) 0 91.69 %
Stock B 0 29,863,674 0 0

Shareholders

NameEquities%Valuation
Baker Bros. Advisors LP
27.94 %
508,323 27.94 % 4 M $
Greenlight Capital, Inc.
8.194 %
149,052 8.194 % 1 M $
Randal Scott
6.316 %
114,884 6.316 % 1 M $
BML Capital Management LLC
2.350 %
42,743 2.350 % 374 001 $
Vanguard Group, Inc. (Subfiler)
1.705 %
31,013 1.705 % 271 364 $
Rustem Ismagilov
0.9737 %
17,712 0.9737 % 154 980 $
Susquehanna Securities LLC
0.8560 %
15,571 0.8560 % 136 246 $
Prelude Capital Management LLC
0.8207 %
14,928 0.8207 % 130 620 $
Kim Popovits
0.7617 %
13,855 0.7617 % 121 231 $
Geode Capital Management LLC
0.6201 %
11,280 0.6201 % 98 700 $
NameEquities%Valuation
Baker Bros. Advisors LP
100.00 %
1,990,914 100.00 % 17 M $

Company contact information

Talis Biomedical Corp.

1375 West Fulton Market Suite 700

60607, Chicago

+

http://www.talis.bio
address Talis Biomedical Corporation(TLIS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TALIS BIOMEDICAL CORPORATION Stock Talis Biomedical Corporation
+22.15% 16.58M
MODERNA, INC. Stock Moderna, Inc.
+26.28% 48.09B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.99% 40.43B
LONZA GROUP AG Stock Lonza Group AG
+46.79% 40.62B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.36B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.36% 24.89B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.47% 19.01B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.58% 12.09B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.75% 11.8B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-2.02% 11.88B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TLIS Stock
  4. Company Talis Biomedical Corporation